Margaret Dalesandro - Sep 1, 2023 Form 4 Insider Report for Ambrx Biopharma Inc. (AMAM)

Role
Director
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Margaret Dalesandro
Stock symbol
AMAM
Transactions as of
Sep 1, 2023
Transactions value $
$0
Form type
4
Date filed
9/6/2023, 05:52 PM
Previous filing
Aug 29, 2023
Next filing
Nov 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMAM Ordinary Shares Award $0 +125K $0.00 125K Sep 1, 2023 Direct F1, F2
transaction AMAM Ordinary Shares Award $0 +70.8K $0.00 70.8K Sep 1, 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares of the Issuer may be represented by the Issuer's American Depositary Shares ("ADSs"). Each ADS represents seven (7) Ordinary Shares of the Issuer.
F2 Represents the grant of Restricted Stock Units (the "RSUs") payable solely in Ordinary Shares of the Issuer that vest in three successive equal annual installments beginning on September 1, 2024, subject to continuous service through such vesting date.
F3 Represents the grant of RSUs payable solely in Ordinary Shares of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the day immediately before the next annual general meeting, subject to continuous service through such vesting date.